Top

Published in:

01-07-2005 | Commentary

Insulin resistance and the metabolic syndrome

Author: L. Landsberg

Published in: Diabetologia | Issue 7/2005

Excerpt

In this issue of Diabetologia, Grassi and colleagues report increased muscle sympathetic nerve activity in patients with a collection of cardiovascular risk factors known as the metabolic syndrome [1]. They present evidence that the increase in sympathetic activity in this syndrome is related to insulin resistance and is associated with decreased baroreflex sensitivity. …

Grassi G, Dell’Oro R, Quarti-Trevano F et al (2005) Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia DOI 10.1007/s00125-005-1798-z

Hansen BC (1999) The metabolic syndrome X. Ann NY Acad Sci 892:1–24PubMed

Landsberg L (2004) The metabolic syndrome: diabetes, obesity and hypertension. In: Birkenhäger WH, Robertson JJS, Zanchetti A (eds) Handbook of hypertension, vol. 22. Elsevier, Amsterdam, pp 245–261

Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L (1981) Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 30:219–225PubMed

Hausberg M, Mark AL, Hoffman, RP, Sinkey CA, Anderson EA (1995) Dissociation of sympathoexcitatory and vasodilator actions of modestly elevated plasma insulin levels. J Hypertens 13:1015–1021PubMed

Troisi RJ, Weiss ST, Parker DR, Sparrow D, Young JB, Landsberg L (1991) Relation of obesity and diet to sympathetic nervous system activity. Hypertension 17:669–677PubMed

Grassi G, Dell’Oro R, Facchini A, Trevano FQ, Bolla GB, Mancia G (2004) Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. J Hypertens 22:2363–2369CrossRefPubMed

Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI (1997) Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 100:270–278PubMed

Kazumi T, Kawaguchi A, Katoh J, Iwahashi M, Yoshino G (1999) Fasting insulin and leptin serum levels are associated with systolic blood pressure independent of percentage body fat and body mass index. J Hypertens 17:1451–1455CrossRefPubMed

10.

Giacchetta G, Faloia E, Sardu C et al (2000) Gene expression of angiotensinogen in adipose tissue of obese patients. Int J Obes 24 [Suppl. 2]:S142–S143

11.

Ward KD, Sparrow D, Landsberg L, Young JB, Vokonas PS, Weiss ST (1994) The relationship of epinephrine excretion to serum lipid levels: the normative aging study. Metabolism 43:509–513CrossRefPubMed

12.

Young JB, Landsberg L (1977) Suppression of sympathetic nervous system during fasting. Science 196:1473–1475PubMed

13.

Young JB, Landsberg L (1977) Stimulation of the sympathetic nervous system during sucrose feeding. Nature 269:615–617

14.

Landsberg L (2001) Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). J Hypertens 19:523–528CrossRefPubMed

15.

Landsberg L, Young JB (1985) Insulin-mediated glucose metabolism in the relationship between dietary intake and sympathetic nervous system activity. Int J Obes 9:63–68

16.

Landsberg L (1986) Diet, obesity and hypertension: a hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. Q J Med 236:1081–1090

17.

Reaven GM (1999) Insulin resistance: a chicken that has come to roost. Ann NY Acad Sci 892:45–57PubMed

Title: Insulin resistance and the metabolic syndrome
Author: L. Landsberg
Publication date: 01-07-2005
Publisher: Springer-Verlag
Published in: Diabetologia / Issue 7/2005
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-005-1818-z

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Insulin resistance and the metabolic syndrome

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 7/2005

Reply to comments on: McAuley KA, Hopkins CM, Smith KJ, McLay RT, Williams SM, Taylor RW, Mann JI (2005) Comparison of high-fat and high-protein diets with a high-carbohydrate diet in insulin-resistant obese women. Diabetologia 48:8–16

Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study

Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B

Activation of opioid μ-receptors by loperamide to improve interleukin-6-induced inhibition of insulin signals in myoblast C2C12 cells

Diabetes in rat pregnancy alters renal calcium and magnesium reabsorption and bone formation in adult offspring

Glucose-induced up-regulation of CD36 mediates oxidative stress and microvascular endothelial cell dysfunction

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page